Home > Boards > Canadian > Medical - Healthcare > Therma Bright Inc. (TBRIF)
Followed By 33
Posts 4329
Boards Moderated 0
Alias Born 11/27/2009

Wednesday, February 23, 2022 9:55:22 AM

Re: None

Post# of 46
$TBRIF Therma Bright Receives Patent for a Device for Applying a Topical Treatment from U.S. Patent & Trademark Office (USPTO)


Toronto, Ontario--(Newsfile Corp. - February 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that on February 4, 2022 the U.S. Patent and Trademark Office allowed a U.S. patent application (US 15/787,599) which covers a device that can apply heat and antimicrobial treatment through a detachable applicator surface comprising copper or silver to provide heat conductivity and a source of antimicrobial agent. The device also includes a light source. This U.S. patent applies to both Therma Bright's InterceptCS™ Cold Sore Prevention Device and TherOZap™ Insect Bite Relief Device.

Specific to the InterceptCS™ device, this heat and antimicrobial treatment technology is combined as the solution for the prevention of cold sores. As for the TherOZap™ device, the treatment technology aims to reduce the inflammatory response, relieving the symptoms of pain, itch and inflammation associated with insect bites and stings. Furthermore, as shared in earlier press releases, the Company engaged a top Virology Research Laboratory in Canada to study the TherOZap™ technology's ability to inactivate live Zika virus in culture media and that the TherOZap™, which utilizes specialized materials, coatings and heat, was able to limit Zika virus ("ZIKV") replication in cell cultures.

"This is exciting news for Therma Bright and our TherOZap™ Insect Relief Device and InterceptCS™ Cold Sore Prevention Device," shared Rob Fia, CEO of Therma Bright. "This allowed U.S. Patent Application further protects our valued intellectual property (IP) as we continue to transform innovation into wellness."

Therma Bright is currently undergoing design upgrades to both devices and expects to complete prototyping during Q2. In addition, the Company plans to continue its research with the new TherOZap™ design on Zika and other mosquito-borne diseases during 2022.

ILUS Confirms Its Second Quarter of 2022 Results, Including a 553% Revenue Increase Over Its Previous Quarter, to $19,677,222 ILUS Aug 15, 2022 2:52 PM

S.E.C.-registered HYUNDAI brand consumer technologies enters the U.S. market with a $100 million stocks and bond offering Aug 15, 2022 12:04 PM

Branded Legacy, Inc. Reduces Issued and Outstanding Shares By 46% BLEG Aug 15, 2022 8:30 AM

Green Battery Minerals Receives Assays from Drilling into Graphite Outcrops on Zone 1. Intersecting 19.5 metres of 35.52% Grade Graphite and 51.20 meters of 22.61% Grade Graphite. GEM Aug 12, 2022 6:07 PM

Alliance Creative Group (ACGX) Reports Revenue of $2,974,489 for Second Quarter of 2022 ACGX Aug 12, 2022 12:40 PM

Progressive Care Reports Second Quarter 2022 Results Highlighted by 4% Growth to $10.0 Million in Revenue RXMD Aug 12, 2022 10:21 AM

PJET Bullish Investment Message Garners New Investment Interest PJET Aug 12, 2022 9:53 AM

VAYK Real Estate Fintech Strategy Builds Momentum and Explores Stock Buyback VAYK Aug 12, 2022 9:46 AM

Branded Legacy, Inc. Eliminates Over 430 Thousand In Debt In 2022 BLEG Aug 12, 2022 9:15 AM

InnerScope Hearing Technologies (OTC: INND) Reports Record Revenues for a Profitable Q2 2022 INND Aug 12, 2022 8:00 AM

Pro Music Rights, Inc., one of the world's largest music licensing companies, announces that it intends to Release its Financials by August 19, 2022 NUVG Aug 11, 2022 11:11 AM

AXTG Partner with Save Planet Earth to digitize and plant 100 million trees with NFTs AXTG Aug 11, 2022 10:15 AM

PURA Announces New Development Expanding Cannabis Market Opportunity PURA Aug 11, 2022 9:34 AM

Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis KTTA Aug 11, 2022 8:35 AM

SinglePoint Acquires Frontline Power Solutions, a Multi-State Licensed Energy Services Company SING Aug 11, 2022 8:30 AM

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y